BioCentury
ARTICLE | Clinical News

Xiaflex: Phase IIb started

February 22, 2016 8:00 AM UTC

Endo began a placebo-controlled, U.S. Phase IIb trial to evaluate 0.84 mg collagenase clostridium histolyticum per session for up to 3 sessions about 21 days apart in about 350 women ages >=18. Patients will receive 12 injections administered during each session into cellulite dimples in the left or right buttock or left or right posterior thigh. ...